Increased levels of γH2AX and p‐RPA32 were also observed after thioparib treatment in the colon cancer HT‐29 (POLQ mutant) cells and PARP‐resistant Capan‐1/TP cells (Appendix Fig S1C and D). This evidence concerns the gene PARP1 and colonic neoplasm.